Vivitrol Approved to Prevent Opioid Relapse

Published October 16, 2010

Vivitrol Approved to Prevent Opioid Relapse
WEDNESDAY, Oct. 13 (HealthDay News) — Vivitrol (naltrexone extended release) has been approved by the U.S. Food and Drug Administration to treat and prevent relapse among opioid-dependent people who have completed a detoxification program.
Read more on HealthDay via Yahoo! News

Ill. receives M to expand drug treatment
SPRINGFIELD, Ill. (AP) — Illinois will receive a $ 13.1 million grant to allow expanded options for more than 7,000 people seeking treatment for drug and alcohol dependency.
Read more on WICS Springfield